Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$79.69 -3.48 (-4.18%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kiniksa Pharmaceuticals International (KNSA) EV to EBIT (2022 - 2026)

Updated

Kiniksa Pharmaceuticals International's (KNSA) EV to EBIT was 94.27 for Q2 2026, down 88.9% from 847.21 a year earlier but up 26.8% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) EV to EBIT (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kiniksa Pharmaceuticals International's EV to EBIT came in at 86.94, down 89.7% year-over-year; for FY2025, it came in at 76.28.

  • By year, EV to EBIT came in at 194.25 in FY2022.
  • Five-year quarterly EV to EBIT spans a low of 46.99 in Q2 2023 and a high of 847.21 in Q2 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 74.33 (Q1 2026), 76.28 (Q4 2025) and 145.05 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Kiniksa Pharmaceuticals International 6.18 Bn 4.92 Bn 220.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.27
Mar 31, 2026 74.33
Dec 31, 2025 76.28
Sep 30, 2025 145.05
Jun 30, 2025 847.21
Jun 30, 2023 46.99
Mar 31, 2023 60.10
Dec 31, 2022 194.25
API Access

Kiniksa Pharmaceuticals International EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=KNSA&period=max&api_key=YOUR_API_KEY